This report summarizes not only GLASS activities but also describes developments over the past years in other surveillance programs led by WHO, including resistance to anti-HIV and anti-tuberculosis (TB) medicines, antimalarial drug efficacy, and environmental surveillance of AMR
the Global Antimicrobial Resistance and Use Surveillance System (GLASS) report highlights the new technical module on AMC surveillance providing a common, standardized set of methodologies for measuring and reporting the consumption of antimicrobial medicines at country, regional, and global levels
This edition of the GLASS report summarizes 2020 data from countries, territories, and areas (CTAs) on AMR rates and trends in common bacteria. An innovative feature of the report is the contextualization of AMR findings based on an analysis of testing coverage which varies substantially
